ALADUCK Trademark

Trademark Overview


On Tuesday, October 26, 2021, a trademark application was filed for ALADUCK with the United States Patent and Trademark Office. The USPTO has given the ALADUCK trademark a serial number of 79326272. The federal status of this trademark filing is REGISTERED as of Tuesday, March 28, 2023. This trademark is owned by SBI Pharmaceuticals Co., Ltd.. The ALADUCK trademark is filed in the Medical Instrument Products category with the following description:

Medical apparatus and instruments for use in endoscopy, microscopy and general surgery procedures; Surgical apparatus and instruments for use in craniotomy, laparotomy and thoracotomy; Medical diagnostic apparatus for testing cancer cells and virus
aladuck

General Information


Serial Number79326272
Word MarkALADUCK
Filing DateTuesday, October 26, 2021
Status700 - REGISTERED
Status DateTuesday, March 28, 2023
Registration Number7008453
Registration DateTuesday, March 28, 2023
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, January 10, 2023

Trademark Statements


Goods and ServicesMedical apparatus and instruments for use in endoscopy, microscopy and general surgery procedures; Surgical apparatus and instruments for use in craniotomy, laparotomy and thoracotomy; Medical diagnostic apparatus for testing cancer cells and virus

Classification Information


International Class010 - Surgical, medical, dental, and veterinary apparatus and instruments, artificial limbs, eyes, and teeth; orthopedic articles; suture materials.
US Class Codes026, 039, 044
Class Status Code6 - Active
Class Status DateSaturday, November 20, 2021
Primary Code010
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameSBI Pharmaceuticals Co., Ltd.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressJP

Party NameSBI Pharmaceuticals Co., Ltd.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressJP

Party NameSBI Pharmaceuticals Co., Ltd.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressJP

Trademark Events


Event DateEvent Description
Friday, November 17, 2023INTERNATIONAL REGISTRATION RENEWED
Monday, August 7, 2023FINAL DECISION TRANSACTION PROCESSED BY IB
Tuesday, July 18, 2023FINAL DISPOSITION NOTICE SENT TO IB
Tuesday, July 18, 2023FINAL DISPOSITION PROCESSED
Wednesday, June 28, 2023FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Tuesday, March 28, 2023NOTICE OF REGISTRATION CONFIRMATION EMAILED
Tuesday, March 28, 2023REGISTERED-PRINCIPAL REGISTER
Monday, January 23, 2023NOTIFICATION PROCESSED BY IB
Tuesday, January 10, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, January 10, 2023PUBLISHED FOR OPPOSITION
Wednesday, January 4, 2023NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Wednesday, January 4, 2023NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Wednesday, December 21, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Thursday, December 8, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, December 1, 2022TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, December 1, 2022CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, December 1, 2022TEAS RESPONSE TO OFFICE ACTION RECEIVED
Sunday, September 4, 2022REFUSAL PROCESSED BY IB
Thursday, August 18, 2022NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Thursday, August 18, 2022REFUSAL PROCESSED BY MPU
Saturday, August 13, 2022NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Friday, August 12, 2022NON-FINAL ACTION WRITTEN
Wednesday, August 3, 2022ASSIGNED TO EXAMINER
Wednesday, November 24, 2021APPLICATION FILING RECEIPT MAILED
Saturday, November 20, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, November 18, 2021SN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB